Consultations governed by SOPs
Your safety isn't a policy.
It's how we're built.
Every prescription we issue is governed by independently audited clinical standards, verified patient eligibility checks, and the same statutory regulators that oversee NHS providers (CQC, GPhC, MHRA, GMC).
> 800,000 patients
> 33,000 reviews
Ongoing clinical support
Regulated by CQC
4.6 Trustpilot rating
Regulated by CEDR
No hidden costs
> 800,000 patients
> 33,000 reviews
Ongoing clinical support
Regulated by CQC
4.6 Trustpilot rating
Regulated by CEDR
No hidden costs
Clinical safety standard
Registered pharmacy
Regulated service
Prescribing safety protocols
Clinical rigour behind every consultation
Our prescribing process is governed end-to-end by a clinical risk framework that's designed, audited, and continuously improved by our in-house clinical governance team. Our clinical governance processes are subject to independent external audit. Audit outcomes are reviewed by the Clinical Safety Officer and result in formal action plans tracked to completion.
GPhC 2026 GUIDANCE
Clinical risk framework
Before any high-risk medicine is prescribed, including GLP-1 weight management injections, each patient pathway passes through a structured risk-stratification process. Clinical triggers are reviewed against our internal clinical risk framework, informed by national safety guidance where applicable.
SOP-AUDIT-CYCLE
Standard operating procedures
Every consultation from initial assessment to prescription issue is governed by a clinically assured SOP. Our SOPs are reviewed no less than annually and following any significant clinical event, and are subject to independent clinical audit.
DCB0160 · NHS ENGLAND
Medical oversight
Numan's Head of Clinical Governance and designated Clinical Safety Officer (CSO) hold accountability for upholding national standards. The CSO is specifically responsible for our compliance with DCB0160 - NHS England's clinical risk management standard for health IT systems.
Identity & Eligibility Verification
We answer to regulators, not just reviews
For weight loss medications, 2026 GPhC guidance requires prescribers to independently verify key patient metrics. Our verification processes were reviewed and updated to comply with the General Pharmaceutical Council's 2026 guidance on independent prescribing via digital services.
Here's exactly how we do that.
Identity confirmed digitally
Every patient completes a digital identity verification check using accredited third-party technology. This confirms you are who you say you are, and prevents misuse of the prescribing service.
Metrics independently verified
For GLP-1 weight management treatments, we independently verify your weight, height, and BMI before any prescription is approved.
Eligibility assessed against clinical criteria
Your verified metrics are assessed against clinically-approved eligibility criteria before a prescription can be issued. Patients who fall outside the criteria are not prescribed.
Ongoing eligibility monitoring
Patients on ongoing treatments are regularly reassessed to ensure that the prescribed treatment continues to be appropriate.
Every side effect report makes the system safer
You can report suspected side effects directly to the MHRA, or through us. Either way, it counts, and we actively use that feedback to improve
What to report
You can report suspected issues with:
→Side effects or adverse reactions to your medication
→Faulty or defective medical devices (e.g., a Mounjaro or Wegovy injection pen that jams or fails)
→Unexpected changes in how a medication is working for you
→Any other safety concern about a medicine or medical product
INTERNAL INCIDENT LEARNING
A learning culture
At Numan, patient-reported incidents aren't filed away; they're the most important input we have. Every adverse event triggers a structured clinical review that feeds directly back into our SOPs and prescribing processes.
Incident reviewed
Every reported incident is reviewed by the clinical governance team within a defined timeframe.
Root cause identified
We use structured root cause analysis to understand not just what happened, but why.
Protocols updated
Learning is translated into SOP updates, prescriber guidance, or patient communication improvements.
Regulatory & Professional Standards
Regulated, registered, and accountable
Numan operates under the oversight of the UK's healthcare regulatory bodies. Our compliance status is verifiable, because we think you should be able to check.
CQC
Care Quality Commission
Our prescribing service is registered with and regulated by the CQC - most recently graded 'Good' -, which is the independent regulator of health and social care in England.
GPhC
General Pharmaceutical Council
Our pharmacy is registered with the GPhC, the regulator for pharmacists, pharmacy technicians, and pharmacy premises in Great Britain.
GMC
General Medical Council
All doctor prescribers within Numan are registered with and regulated by the GMC.
MHRA
Medicines & Healthcare Regulatory Agency
We comply with MHRA standards for the supply of medicines and report adverse events through the Yellow Card scheme.
Service transparency
In line with GPhC requirements for online prescribing services, we publish the following information about our prescribing service.
| Service address | Floor 4, Farringdon Point, 33 Farringdon Road, London, England, EC1M 3JF. |
|---|---|
| Prescriber type | Doctors (GMC-registered) and non-medical prescribers (GPhC AND NMC registered) |
| CQC registration | 1-6118870417 |
| GPhC registration | 9011408 |
Clinical team
The people responsible for your care
GPhC guidance requires us to name the clinicians providing our prescribing service. All registration numbers are publicly verifiable on the relevant professional register.
Danielle Brightman
Clinical Director
MPharm PgDip PCert
Zoe Griffiths
VP of Behavioural Medicine
BSc (Hons) RD SCOPE
Victoria Rogers
Head of AI Coaching and Behavioural Science
MSc BSc
Dr Michael Lacey
Numan Doctor
MBChB BSc (Hons) MRCGP
Dr Dimitris Schizas
Numan Doctor
MBBS MRCGP MSC BSSM
Updated: